iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) gapped up before the market opened on Tuesday after Truist Financial raised their price target on the stock from $80.00 to $95.00. The stock had previously closed at $62.10, but opened at $70.11. Truist Financial currently has a buy rating on the stock. iRhythm Technologies shares last traded at $72.78, with a volume of 439,491 shares trading hands.
IRTC has been the topic of a number of other reports. Needham & Company LLC decreased their price target on iRhythm Technologies from $138.00 to $119.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Canaccord Genuity Group lifted their target price on shares of iRhythm Technologies from $122.00 to $137.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Oppenheimer dropped their price target on shares of iRhythm Technologies from $165.00 to $145.00 and set an “outperform” rating for the company in a research report on Friday, August 2nd. The Goldman Sachs Group initiated coverage on shares of iRhythm Technologies in a research report on Friday, October 4th. They issued a “neutral” rating and a $78.00 price objective on the stock. Finally, StockNews.com lowered shares of iRhythm Technologies from a “hold” rating to a “sell” rating in a report on Friday, September 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $113.90.
Check Out Our Latest Stock Report on iRhythm Technologies
Insider Buying and Selling
Institutional Trading of iRhythm Technologies
Several hedge funds and other institutional investors have recently made changes to their positions in IRTC. Headlands Technologies LLC grew its stake in shares of iRhythm Technologies by 10,650.0% in the first quarter. Headlands Technologies LLC now owns 430 shares of the company’s stock worth $50,000 after acquiring an additional 426 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in iRhythm Technologies by 79.6% in the 2nd quarter. Nisa Investment Advisors LLC now owns 625 shares of the company’s stock worth $67,000 after acquiring an additional 277 shares during the last quarter. SG Americas Securities LLC bought a new position in iRhythm Technologies in the 1st quarter valued at approximately $126,000. Russell Investments Group Ltd. boosted its stake in iRhythm Technologies by 79,700.0% during the 1st quarter. Russell Investments Group Ltd. now owns 1,596 shares of the company’s stock valued at $185,000 after purchasing an additional 1,594 shares during the last quarter. Finally, nVerses Capital LLC increased its holdings in shares of iRhythm Technologies by 400.0% in the 3rd quarter. nVerses Capital LLC now owns 2,000 shares of the company’s stock worth $148,000 after purchasing an additional 1,600 shares in the last quarter.
iRhythm Technologies Stock Performance
The business has a fifty day moving average price of $68.28 and a 200-day moving average price of $86.84. The company has a quick ratio of 6.76, a current ratio of 6.92 and a debt-to-equity ratio of 6.50. The stock has a market capitalization of $2.31 billion, a P/E ratio of -17.58 and a beta of 1.22.
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.61) EPS for the quarter, topping the consensus estimate of ($0.89) by $0.28. The company had revenue of $148.05 million during the quarter, compared to analyst estimates of $146.15 million. iRhythm Technologies had a negative return on equity of 84.14% and a negative net margin of 24.50%. iRhythm Technologies’s revenue was up 19.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.61) earnings per share. On average, sell-side analysts expect that iRhythm Technologies, Inc. will post -2.66 EPS for the current year.
About iRhythm Technologies
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Featured Articles
- Five stocks we like better than iRhythm Technologies
- Using the MarketBeat Dividend Yield Calculator
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- 3 Fintech Stocks With Good 2021 Prospects
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is Forex and How Does it Work?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.